Absolutely agree , look at the rewards to Acadia for bringing 2 rare disease neurological drugs to market ? Today they are worth less than they were BEFORE Nuplazid passed phase 3 and got approved and BEFORE they took Trofinetide through the same costly process . They are valued at what they were in 2015 !!!
What's the point going ahead with these outcomes ?
- Forums
- ASX - By Stock
- NEU
- Acadia
Acadia, page-794
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.85 |
Change
0.240(1.76%) |
Mkt cap ! $1.784B |
Open | High | Low | Value | Volume |
$13.60 | $14.00 | $13.51 | $2.918M | 211.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1 | $13.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.85 | 798 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 206 | 13.820 |
19 | 921 | 13.810 |
14 | 1728 | 13.800 |
5 | 484 | 13.790 |
4 | 1125 | 13.780 |
Price($) | Vol. | No. |
---|---|---|
13.830 | 478 | 9 |
13.840 | 1007 | 7 |
13.850 | 961 | 4 |
13.860 | 1889 | 4 |
13.870 | 413 | 3 |
Last trade - 15.42pm 13/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online